Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease-results of a multicenter Canadian study. | Synapse
March 28, 2026Open Access
Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease-results of a multicenter Canadian study.
Key Points
This research aims to understand parent preferences regarding the safety and effectiveness of treatments for pediatric inflammatory bowel disease (IBD).
Conducted a multicenter study across Canada
Surveyed parents of children with IBD regarding their treatment preferences
Analyzed responses to determine valued aspects of therapies
Parents prioritize safety as equally important to effectiveness in treatment choices
Recognition of parent preferences may enhance shared decision-making
Identified novel therapies like FMT are important in discussions about treatment options
Abstract
Parents value both safety and effectiveness in IBD treatment decisions. Recognizing these preferences may support shared decision-making, particularly when discussing novel therapies like FMT.